|Bid||59.99 x 900|
|Ask||60.00 x 800|
|Day's range||59.03 - 60.05|
|52-week range||57.49 - 89.70|
|Beta (5Y monthly)||0.60|
|PE ratio (TTM)||29.95|
|Forward dividend & yield||1.16 (1.94%)|
|Ex-dividend date||01 Sept 2022|
|1y target est||N/A|
DEERFIELD, Ill., July 28, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2022.
DEERFIELD, Ill., July 12, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on October 3, 2022, to shareholders of record as of September 2, 2022. The indicated annual dividend rate is $1.16 per share of common stock.
DEERFIELD, Ill., June 27, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, today released its 2021 Corporate Responsibility Report, demonstrating how the company is progressing toward its 2030 Corporate Responsibility Commitment and Goals. The report highlights the continued progress Baxter has made to advance environmental, social and governance (ESG) performance across its operations and philanthropic programs.